£520.00

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

Price data last checked 80 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 11 days • 11 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 28 January 2026 31 January 2026 02 February 2026 05 February 2026

Price Distribution

Price distribution over 11 days • 1 price levels

Days at Price
11 days 0 3 6 8 11 £520 Days at Price

Price Analysis

Most common price: £520 (11 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 11 days

Product Specifications
Format
paperback
ASIN
B0BLQYGZW8
Category
Books > Subjects
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Amyloidosis Treatments in India
98% match

The 2023-2028 Outlook for Amyloidosis Treatments in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
97% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
97% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
97% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
97% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Amyloidosis Treatments for US Zip Codes
97% match

The 2023-2028 Outlook for Amyloidosis Treatments for US Zip Codes

£490.00 24 Jan 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in the United States
97% match

The 2023-2028 Outlook for Macular Degeneration Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
97% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
97% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
97% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Diabetes Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetes Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Alopecia Treatments in the United States
97% match

The 2023-2028 Outlook for Alopecia Treatments in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States
97% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Asthma Treatments in the United States
96% match

The 2023-2028 Outlook for Asthma Treatments in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States
96% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Osteoporosis Treatments in the United States
96% match

The 2023-2028 Outlook for Osteoporosis Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States
96% match

The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Hyperpigmentation Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Hyperpigmentation Disorders Treatments in the United States

£520.00 13 Jan 2026